Healthcare Sales & Marketing Network News: BioSpecifics Technologies

Searching News Database: BioSpecifics Technologies

HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals

HSMN NewsFeed - 1 Mar 2011
BioSpecifics Technologies Corp. Announces Approval of XIAPEX(R) for Treatment of Dupuytren's Contracture in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Dec 2008
BioSpecifics Announces Partnership Between Pfizer and Auxilium for XIAFLEX(TM) in Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Feb 2007
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2006
Auxilium Pharmaceuticals Announces Top-Line Results from a Pivotal Efficacy Study of AA4500 in Dupuytren's Disease and Revises 2006 Financial Guidance
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2006
HEALTHPOINT Acquires Collagenase Topical Business from BioSpecifics Technologies Corp.
Biopharmaceuticals Mergers & Acquisitions

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
BioSpecifics Technologies
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.